Efficacy and safety of immunoradiotherapy for advanced non-small cell lung cancer: a retrospective comparative cohort study

BACKGROUND: Treatment of radiotherapy (RT) combined with immune checkpoint inhibitor (ICI) may remarkably improve the prognosis in patients with metastatic non-small cell lung cancer (NSCLC). However, the treatment time of RT, irradiated lesion and the optimum combined scheme, have not been fully de...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yifan, Sun, Xiaorong, Hou, Yichen, Zhang, Mingzhu, Tan, Weiyue, Zhang, Yi, Wang, Jie, Zheng, Zhonghang, Li, Chaozhuo, Qi, Haoran, Hu, Mengyu, Xing, Ligang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323553/
https://www.ncbi.nlm.nih.gov/pubmed/37426122
http://dx.doi.org/10.21037/jtd-22-1685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323553/
https://www.ncbi.nlm.nih.gov/pubmed/37426122
http://dx.doi.org/10.21037/jtd-22-1685

Ejemplares similares